[Edaily Reporter Kwon Oh-seok] #TPC Robotics, a company specializing in AI-driven autonomous manufacturing technology and robot components, announced on the 15th that it is accelerating the expansion of its robotics business by establishing an AI robotics research institute in line with its strategic partnership with Chinese humanoid robot company 'HCBOT' (Zhejiang Hechuan Humanoid Robot Co., Ltd.). The company explained that, in accordance with the roadmap of the “Strategic Cooperation Agreement on Joint Development and Production” signed last April, it has begun full-scale efforts to internalize robot drive and control technologies and strengthen its business competitiveness.

A company official explained, “While we have previously operated our own research institute for the development of pneumatic and motion technologies, we have established a separate AI robot research institute to fully launch our robotics business,” adding, “We have completed the recruitment of specialized personnel and the coordination of the detailed scope of cooperation with HCBOT.”
The official continued, “We plan to launch robot actuators under our own brand in August and begin full-scale sales targeting industrial and humanoid robot developers. By the end of this year, we intend to proceed in stages through the AI Robotics Research Institute to secure differentiated robotic automation cell solutions, AI-based smart actuators, and integrated solutions that bundle actuator and control technologies.”
TPC Robotics changed its corporate name from “TPC Mechatronics” to its current name last March, declaring a strategic shift toward becoming a robotics-focused company. The establishment of this AI Robotics Research Institute holds strategic significance not only for enhancing market standing through the expansion of its robot product portfolio but also for strengthening its comprehensive robotics capabilities, which now encompass software and control technologies in addition to hardware.
The company plans to broaden the foundation of its AI and robotics business through collaboration with affiliates and partners in the bio and mechatronics sectors, alongside the operation of the AI Robotics Research Institute. First, it will jointly develop next-generation AI rehabilitation robots with Huka Systems, a company specializing in gait rehabilitation robots. Huka Systems supplies gait rehabilitation robots that utilize its proprietary embedded PCBs, load cells, and encoder-based control algorithms. The company has received recognition for its technological capabilities, having obtained medical device approvals in Korea, the U.S. (FDA), Vietnam, and the United Arab Emirates.
Among these products, the “Robot-Assisted Orthopedic Exercise Device” is registered as a Class 3 medical device with the Ministry of Food and Drug Safety, making it eligible for medical reimbursement. Following exports to hospitals in Vietnam, the device is scheduled to be supplied to major hospitals in India, including the Government Rehabilitation Research Institute (RRTI) and AIIMS, in June. TPC Robotics expects to enhance rehabilitation efficiency by integrating AI capabilities to provide personalized data tailored to patients with central nervous system injuries, such as stroke.
In another initiative, the company is partnering with T1 Bio, a specialist in molecular diagnostic devices, to develop an AI-based all-in-one diagnostic device for medical and healthcare use. T1 Bio has been selected for the “Agent AI-based Rapid Food Safety Testing System” project under the Ministry of Trade, Industry and Energy’s “2026 AI Application Product Rapid Commercialization Support Program” and is scheduled to conduct research for one year, with food company Ourhome participating as a joint development partner and client.
The core of the device currently under development is a system that fully automates the PCR-based pretreatment process for detecting foodborne pathogens and utilizes AI to rapidly generate and deliver test results. Amid growing demand for disease management and prevention, TPC Robotics’ strategy is to participate in the development of AI algorithms through to the mass production stage, thereby securing a new growth engine that combines robotics and biotechnology.